Home-based self-collected vaginal specimens detect more cervical lesions and cancers than cytology
Hilden, Germany, and Gaithersburg, Md. (ots) - Vaginal self-collection for Hybrid Capture®-based HPV testing increases screening coverage and is more sensitive than Pap smear shows a Mexican study published today online in the Lancet ... lisez la suite ici... Qiagen N.V.
Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Hanoi, Vietnam (ots/PRNewswire) - QIAGEN was featured this week for its efforts to eliminate cervical cancer at the 14th annual Global Summit of Women in Hanoi, Vietnam. CEO Peer Schatz came to this prominent international platform to issue a ... lisez la suite ici... Qiagen N.V.
Study Finds New Version of QIAGEN's HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment
Beijing, November 8 (ots/PRNewswire) - - Research Shows the New Test is Accurate, Simple to Run and Requires Minimal Resources Research demonstrating the potential of a special type of HPV test developed by QIAGEN with support from PATH ... lisez la suite ici... Qiagen N.V.
NEJM Report Finds HPV Test More Effective Than Pap in Determining Cervical Cancer Risk
Gaithersburg, Maryland and Hilden, Germany (ots/PRNewswire) - The first randomized, controlled study in North America of HPV testing as a stand-alone screen concluded that it is almost 40 percent more accurate than traditional cytology (the Pap ... lisez la suite ici... Qiagen N.V.

